Kellogg INSIGHT
Kellogg faculty bring their latest research emphasizing key findings.In this issue:
Name-Letter Branding Miguel Brendl
Read More
Health Enterprise Management HEMA
Offered by the Health Enterprise Management Program
|
Students must complete either the Health Industry track or the Medical Products track. To do so, they are required to take the foundations course and three additional courses that count towards their chosen track. Of the three additional courses, at least one must be specific to the chosen track. | |||
| The foundations courses is: | |||
| HEMA-440 | Introduction to Health Enterprise Management* | ||
| *Students may waive HEMA-440 upon approval of instructor. Students who waive HEMA-440 must still take four courses within a track. | |||
|
Courses that count towards both the Health Industry and Biotech and Medical Products tracks: | |||
| HEMA-499 | Independent Study | ||
| MGMT-444 | Healthcare Economics | ||
| INTL-442 | International Health Industry Management | ||
| MORS-454A / HEMA-452B | Advanced Strategic Management in Healthcare | ||
| Courses specific to the Health Industry track: | |||
| HEMA-441 | Health Policy | ||
| HEMA-451 | Legal Issues in Healthcare | ||
| HEMA-499 | Independent Study | ||
| HEMA-512 | Health Industry Management Practicum | ||
| ACCT-432 | Info Technology in Healthcare Management | ||
| ACCT-479 | Financial Assessment of Healthcare Entities | ||
| INTL-473 | Global Initiatives in Management (Global Health Trip Section) | ||
| MGMT-469 | Empirical Methods in Strategy | ||
| Courses specific to the Biotech and Medical Products track: | |||
| HEMA-453 | Managerial Challenges in Pharma, Biotech and Device | ||
| HEMA-499 | Independent Study | ||
| HEMA-913 | Biotech and Medical Products Practicum | ||
| HEMA-914 | Biomedical Marketing | ||
| HEMA-915 | Medical Innovations I | ||
| HEMA-916 | Medical Innovations II | ||
| FINC-932 | Case Studies in Venture Investment | ||
| INTL-473 | Global Initiatives in Management (Global Health Trip Section) | ||
| MGMT-463 | Management of Technology* *Only Prof. Scott Stern’s sections count towards the major. | ||
| TECH-441 | Intellectual Capital Management | ||
| Special Competency in Health Enterprise Excellence
Kellogg offers students interested in the health sector an opportunity to study deeper into the field. Students who wish to do so may complete the Special Competency in Health Enterprise Excellence Major (SCHEMA). SCHEMA majors must complete the either the Health Industry or Biotech and Medical Products track, plus two additional courses from either track. Students may mix and match the additional courses required to complete the SCHEMA major. | |||
| Last edited November 9, 2009. For any questions regarding this page, please email kellogg-registrar@kellogg.northwestern.edu | |||
Information for Full-Time MBA students in the class of 2009 and Part-Time MBA students who were enrolled prior to fall 2008
Only Full-Time MBA students in the class of 2009 and Part-Time MBA students who were enrolled prior to fall 2008 are eligible to major in Biotechnology Management BIOT and Health Industry Management HIMT.
All students who declare the Health Enterprise Management (HEMA) major must meet the requirements for that major.
